Mar 11, 2026
Mar 06, 2026
Mar 04, 2026
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst…
Mar 02, 2026
Rallybio Corporation (NASDAQ:RLYB) shares are up Monday following a merger agreement with Candid Therapeutics Inc. This news has generated excitement among investors as the combined company aims to advance a leading portfolio of T-cell engager therapeutics for autoimmune diseases, adding momentum…
Feb 27, 2026
Late Thursday, Toby Pohlen, co-founder of xAI, took to X to announce his decision to depart the company after three years. “Three years, thousands of PRs, and a million jokes….” wrote Pohlen as he penned his exit note. He expressed…
Feb 25, 2026
On CNBC's “Halftime Report Final Trades,” Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, named Martin Marietta Materials, Inc. (NYSE:MLM) as his final trade. On the earnings front, Martin Marietta Materials reported mixed fourth-quarter results on Feb. 11. Revenue…
Feb 23, 2026
Teva Pharmaceuticals Industries Ltd (NYSE:TEVA) on Friday announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for olanzapine extended-release injectable suspension. Potential FDA Approval For Schizophrenia Drug The marketing application for TEV-‘749 is…
